Summary
Transparent collaborations between patient organisations and clinical research sponsors can identify and address the unmet needs of patients and caregivers. These insights can improve clinical trial participant experience and delivery of medical innovations necessary to advance health outcomes and standards of care. Roennow et al. share their experiences from such a collaboration undertaken surrounding the SENSCIS® clinical trial and discuss its impact during, and legacy beyond, the trial.
Collaboration between patient organisations and a clinical research sponsor in a rare disease condition: learnings from a community advisory board and best practice for future collaborations (16 December 2020)
https://bmjopen.bmj.com/content/10/12/e039473
0
reactions so far
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now